nach oben

Erschienen in:

09.07.2020 | Review Article

Evidence on ankle injections for osteochondral lesions and osteoarthritis: a systematic review and meta-analysis

verfasst von: Angelo Boffa, Davide Previtali, Giorgio Di Laura Frattura, Francesca Vannini, Christian Candrian, Giuseppe Filardo

Erschienen in: International Orthopaedics | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the evidence supporting safety and effectiveness of intra-articular injective treatments for ankle lesions ranging from osteochondral lesions of the talus (OLT) to osteoarthritis (OA).

Methods

A systematic review and a meta-analysis were performed on PubMed, Embase, and Cochrane Library in March 2020. Safety was evaluated through the reported side effects and effectiveness through the scores used. The quality of the studies was assessed using the Cochrane Collaboration Risk of Bias 2.0 tool and the Downs and Black checklist. For each outcome, the quality of evidence was graded according to GRADE guidelines.

Results

Twenty-four studies (21 for OA, 3 for OLT) were included on hyaluronic acid (HA), platelet-rich plasma (PRP), saline, methylprednisolone, botulinum toxin type A (BoNT-A), mesenchymal stem cells (MSCs), and prolotherapy. No severe adverse events were reported. For OLT, a comparison was possible between HA and PRP showing no significant difference. For ankle OA, a significant difference favouring HA versus saline was documented at six months (p < 0.001). The GRADE level of evidence was very low.

Conclusion

This meta-analysis supports the safety of intra-articular treatment for ankle OA and OLT, while only a very low evidence supports the efficacy of HA in terms of better results versus placebo for the treatment of ankle OA, and other conclusions are hindered by the scarcity of the available literature. This urges further and stronger trials to specifically investigate potential and limitations of these different injective approaches for the treatment of OLT and ankle OA.

Nur mit Berechtigung zugänglich

Kraeutler MJ, Kaenkumchorn T, Pascual-Garrido C, Wimmer MA, Chubinskaya S (2017) Peculiarities in ankle cartilage. Cartilage 8:12–18. https://doi.org/10.1177/1947603516642572CrossRefPubMed

Badekas T, Takvorian M, Souras N (2013) Treatment principles for osteochondral lesions in foot and ankle. Int Orthop 37:1697–1706. https://doi.org/10.1007/s00264-013-2076-1CrossRefPubMedPubMedCentral

Grogan KA, Chang TJ, Salk RS (2009) Update on viscosupplementation in the treatment of osteoarthritis of the foot and ankle. Clin Podiatr Med Surg 26:199–204. https://doi.org/10.1016/j.cpm.2009.03.001CrossRefPubMed

Gianakos AL, Yasui Y, Hannon CP, Kennedy JG (2017) Current management of talar osteochondral lesions. World J Orthop 8:12–20. https://doi.org/10.5312/wjo.v8.i1.12CrossRefPubMedPubMedCentral

Witteveen AG, Hofstad CJ, Kerkhoffs GM (2015) Hyaluronic acid and other conservative treatment options for osteoarthritis of the ankle. Cochrane Database Syst Rev:CD010643. https://doi.org/10.1002/14651858.CD010643.pub2

Chang KV, Hsiao MY, Chen WS, Wang TG, Chien KL (2013) Effectiveness of intra-articular hyaluronic acid for ankle osteoarthritis treatment: a systematic review and meta-analysis. Arch Phys Med Rehabil 94:951–960. https://doi.org/10.1016/j.apmr.2012.10.030CrossRefPubMed

Barg A, Pagenstert GI, Hugle T et al (2013) Ankle osteoarthritis: etiology, diagnostics, and classification. Foot Ankle Clin 18:411–426. https://doi.org/10.1016/j.fcl.2013.06.001CrossRefPubMed

Barakat AS, Ibrahim NM, Elghobashy O, Sultan AM, Abdel-Kader KFM (2019) Prevention of post-traumatic osteoarthritis after intra-articular knee fractures using hyaluronic acid: a randomized prospective pilot study. Int Orthop 43:2437–2445. https://doi.org/10.1007/s00264-019-04360-8CrossRefPubMed

Roato I, Belisario DC, Compagno M et al (2019) Concentrated adipose tissue infusion for the treatment of knee osteoarthritis: clinical and histological observations. Int Orthop 43:15–23. https://doi.org/10.1007/s00264-018-4192-4CrossRefPubMed

10.

Bowman EN, Hallock JD, Throckmorton TW, Azar FM (2018) Hyaluronic acid injections for osteoarthritis of the knee: predictors of successful treatment. Int Orthop 42:733–740. https://doi.org/10.1007/s00264-017-3731-8CrossRefPubMed

11.

Hong Z, Chen J, Zhang S et al (2019) Intra-articular injection of autologous adipose-derived stromal vascular fractions for knee osteoarthritis: a double-blind randomized self-controlled trial. Int Orthop 43:1123–1134. https://doi.org/10.1007/s00264-018-4099-0CrossRefPubMed

12.

Evans CH, Kraus VB, Setton LA (2014) Progress in intra-articular therapy. Nat Rev Rheumatol 10:11–22. https://doi.org/10.1038/nrrheum.2013.159CrossRefPubMed

13.

Kon E, Filardo G, Drobnic M et al (2012) Non-surgical management of early knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc 20:436–449. https://doi.org/10.1007/s00167-011-1713-8CrossRefPubMed

14.

Jones IA, Togashi R, Wilson ML, Heckmann N, Vangsness CT Jr (2019) Intra-articular treatment options for knee osteoarthritis. Nat Rev Rheumatol 15:77–90. https://doi.org/10.1038/s41584-018-0123-4CrossRefPubMedPubMedCentral

15.

Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6:e1000100. https://doi.org/10.1371/journal.pmed.1000100CrossRefPubMedPubMedCentral

16.

Higgins JPT GSe (2008) Cochrane handbook for systematic reviews of interventions. Available from wwwhandbookcochraneorg 2008 Vol.[updated February 2008]; The Cochrane Collaboration, Version 5.0.0

17.

Sterne JAC, Savovic J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https://doi.org/10.1136/bmj.l4898CrossRefPubMed

18.

Downs SH, Black N (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 52:377–384. https://doi.org/10.1136/jech.52.6.377CrossRefPubMedPubMedCentral

19.

Ryan RHS (2016) How to GRADE the quality of the evidence. Cochrane Consumers and Communication Group available at http://cccrg.cochrane.org/author-resources Version 30 December 2016

20.

Hauser RA, Orlofsky A (2013) Regenerative injection therapy with whole bone marrow aspirate for degenerative joint disease: a case series. Clin Med Insights Arthritis Musculoskelet Disord 6:65–72. https://doi.org/10.4137/CMAMD.S10951CrossRefPubMedPubMedCentral

21.

Salk R, Chang T, D’Costa W, Soomekh D, Grogan K (2005) Viscosupplementation (hyaluronans) in the treatment of ankle osteoarthritis. Clin Podiatr Med Surg 22(585–597):vii. https://doi.org/10.1016/j.cpm.2005.07.007CrossRef

22.

Akpancar S, Gul D (2019) Comparison of platelet rich plasma and prolotherapy in the management of osteochondral lesions of the talus: a retrospective cohort study. Med Sci Monit 25:5640–5647. https://doi.org/10.12659/MSM.914111CrossRefPubMedPubMedCentral

23.

Mei-Dan O, Carmont MR, Laver L, Mann G, Maffulli N, Nyska M (2012) Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med 40:534–541. https://doi.org/10.1177/0363546511431238CrossRefPubMed

24.

Mei-Dan O, Maoz G, Swartzon M et al (2008) Treatment of osteochondritis dissecans of the ankle with hyaluronic acid injections: a prospective study. Foot Ankle Int 29:1171–1178. https://doi.org/10.3113/FAI.2008.1171CrossRefPubMed

25.

Younger ASE, Penner M, Wing K et al (2019) Nonanimal hyaluronic acid for the treatment of ankle osteoarthritis: a prospective, single-arm cohort study. J Foot Ankle Surg 58:514–518. https://doi.org/10.1053/j.jfas.2018.10.003CrossRefPubMed

26.

Yinze Qi YM, Chen Z (2018) Effects of ankle joint injection combined with massotherapy on function recovery and quality of life of ankle joint osteoarthrosis patients. Int J Clin Exp Med 11(11):12547–12554

27.

Fukawa T, Yamaguchi S, Akatsu Y, Yamamoto Y, Akagi R, Sasho T (2017) Safety and efficacy of intra-articular injection of platelet-rich plasma in patients with ankle osteoarthritis. Foot Ankle Int 38:596–604. https://doi.org/10.1177/1071100717700377CrossRefPubMed

28.

Murphy EP, Curtin M, McGoldrick NP, Thong G, Kearns SR (2017) Prospective evaluation of intra-articular sodium hyaluronate injection in the ankle. J Foot Ankle Surg 56:327–331. https://doi.org/10.1053/j.jfas.2016.09.017CrossRefPubMed

29.

Repetto I, Biti B, Cerruti P, Trentini R, Felli L (2017) Conservative treatment of ankle osteoarthritis: can platelet-rich plasma effectively postpone surgery? J Foot Ankle Surg 56:362–365. https://doi.org/10.1053/j.jfas.2016.11.015CrossRefPubMed

30.

Bossert M, Boublil D, Parisaux JM, Bozgan AM, Richelme E, Conrozier T (2016) Imaging guidance improves the results of viscosupplementation with HANOX-M-XL in patients with ankle osteoarthritis: results of a clinical survey in 50 patients treated in daily practice. Clin Med Insights Arthritis Musculoskelet Disord 9:195–199. https://doi.org/10.4137/CMAMD.S40401CrossRefPubMedPubMedCentral

31.

Emadedin M, Ghorbani Liastani M, Fazeli R et al (2015) Long-term follow-up of intra-articular injection of autologous mesenchymal stem cells in patients with knee, ankle, or hip osteoarthritis. Arch Iran Med 18(6):336–344

32.

Han SH, Park DY, Kim TH (2014) Prognostic factors after intra-articular hyaluronic acid injection in ankle osteoarthritis. Yonsei Med J 55:1080–1086. https://doi.org/10.3349/ymj.2014.55.4.1080CrossRefPubMedPubMedCentral

33.

Sun SF, Hsu CW, Lin HS, Chou YJ, Chen JY, Wang JL (2014) Efficacy of intraarticular botulinum toxin A and intraarticular hyaluronate plus rehabilitation exercise in patients with unilateral ankle osteoarthritis: a randomized controlled trial. J Foot Ankle Res 7:9. https://doi.org/10.1186/1757-1146-7-9CrossRefPubMedPubMedCentral

34.

Angthong C, Khadsongkram A, Angthong W (2013) Outcomes and quality of life after platelet-rich plasma therapy in patients with recalcitrant hindfoot and ankle diseases: a preliminary report of 12 patients. J Foot Ankle Surg 52:475–480. https://doi.org/10.1053/j.jfas.2013.04.005CrossRefPubMed

35.

Lucas YHJ, Darcel V, Chauveaux D, Laffenetre O (2013) Viscosupplementation of the ankle: a prospective study with an average follow-up of 45.5 months. Orthop Traumatol Surg Res 99:593–599. https://doi.org/10.1016/j.otsr.2013.02.008CrossRef

36.

DeGroot H 3rd, Uzunishvili S, Weir R, Al-omari A, Gomes B (2012) Intra-articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double-blind, placebo-controlled study. J Bone Joint Surg Am 94:2–8. https://doi.org/10.2106/JBJS.J.01763CrossRefPubMed

37.

Sun SF, Hsu CW, Sun HP, Chou YJ, Li HJ, Wang JL (2011) The effect of three weekly intra-articular injections of hyaluronate on pain, function, and balance in patients with unilateral ankle arthritis. J Bone Joint Surg Am 93:1720–1726. https://doi.org/10.2106/JBJS.J.00315CrossRefPubMed

38.

Mei-Dan O, Kish B, Shabat S et al (2010) Treatment of osteoarthritis of the ankle by intra-articular injections of hyaluronic acid: a prospective study. J Am Podiatr Med Assoc 100:93–100. https://doi.org/10.7547/1000093CrossRefPubMed

39.

Witteveen AG, Sierevelt IN, Blankevoort L, Kerkhoffs GM, van Dijk CN (2010) Intra-articular sodium hyaluronate injections in the osteoarthritic ankle joint: effects, safety and dose dependency. Foot Ankle Surg 16:159–163. https://doi.org/10.1016/j.fas.2009.10.003CrossRefPubMed

40.

Cohen MM, Altman RD, Hollstrom R, Hollstrom C, Sun C, Gipson B (2008) Safety and efficacy of intra-articular sodium hyaluronate (Hyalgan) in a randomized, double-blind study for osteoarthritis of the ankle. Foot Ankle Int 29:657–663. https://doi.org/10.3113/FAI.2008.0657CrossRefPubMed

41.

Karatosun V, Unver B, Ozden A, Ozay Z, Gunal I (2008) Intra-articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long-term follow-up. Clin Exp Rheumatol 26:288–294PubMed

42.

Luciani D, Cadossi M, Tesei F, Chiarello E, Giannini S (2008) Viscosupplementation for grade II osteoarthritis of the ankle: a prospective study at 18 months’ follow-up. Chir Organi Mov 92:155–160. https://doi.org/10.1007/s12306-008-0066-zCrossRefPubMed

43.

Witteveen AG, Giannini S, Guido G et al (2008) A prospective multi-centre, open study of the safety and efficacy of hylan G-F 20 (Synvisc) in patients with symptomatic ankle (talo-crural) osteoarthritis. Foot Ankle Surg 14:145–152. https://doi.org/10.1016/j.fas.2008.01.001CrossRefPubMed

44.

Salk RS, Chang TJ, D’Costa WF, Soomekh DJ, Grogan KA (2006) Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double-blind pilot study. J Bone Joint Surg Am 88:295–302. https://doi.org/10.2106/JBJS.E.00193CrossRefPubMed

45.

Sun SF, Chou YJ, Hsu CW et al (2006) Efficacy of intra-articular hyaluronic acid in patients with osteoarthritis of the ankle: a prospective study. Osteoarthr Cartil 14:867–874. https://doi.org/10.1016/j.joca.2006.03.003CrossRef

46.

Previtali D, Merli G, Di Laura FG, Candrian C, Zaffagnini S, Filardo G (2020) The long-lasting effects of “placebo injections” in knee osteoarthritis: a meta-analysis. Cartilage:1947603520906597. https://doi.org/10.1177/1947603520906597

47.

Santilli V, Paoloni M, Mangone M, Alviti F, Bernetti A (2016) Hyaluronic acid in the management of osteoarthritis: injection therapies innovations. Clin Cases Miner Bone Metab 13:131–134. https://doi.org/10.11138/ccmbm/2016.13.2.131CrossRefPubMedPubMedCentral

48.

Bowman S, Awad ME, Hamrick MW, Hunter M, Fulzele S (2018) Recent advances in hyaluronic acid based therapy for osteoarthritis. Clin Transl Med 7:6. https://doi.org/10.1186/s40169-017-0180-3CrossRefPubMedPubMedCentral

49.

Bannuru RR, Osani MC, Vaysbrot EE et al (2019) OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr Cartil 27:1578–1589. https://doi.org/10.1016/j.joca.2019.06.011CrossRef

50.

Bruyere O, Honvo G, Veronese N et al (2019) An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum 49:337–350. https://doi.org/10.1016/j.semarthrit.2019.04.008CrossRefPubMed

51.

Huang G, Hua S, Yang T, Ma J, Yu W, Chen X (2018) Platelet-rich plasma shows beneficial effects for patients with knee osteoarthritis by suppressing inflammatory factors. Exp Ther Med 15:3096–3102. https://doi.org/10.3892/etm.2018.5794CrossRefPubMedPubMedCentral

52.

Carmona JU, Rios DL, Lopez C, Alvarez ME, Perez JE (2017) Proinflammatory and anabolic gene expression effects of platelet-rich gel supernatants on equine synovial membrane explants challenged with lipopolysaccharide. Vet Med Int 2017:6059485. https://doi.org/10.1155/2017/6059485CrossRefPubMedPubMedCentral

53.

Filardo G, Kon E, Roffi A, Di Matteo B, Merli ML, Marcacci M (2015) Platelet-rich plasma: why intra-articular? A systematic review of preclinical studies and clinical evidence on PRP for joint degeneration. Knee Surg Sports Traumatol Arthrosc 23:2459–2474. https://doi.org/10.1007/s00167-013-2743-1CrossRefPubMed

54.

Gato-Calvo L, Magalhaes J, Ruiz-Romero C, Blanco FJ, Burguera EF (2019) Platelet-rich plasma in osteoarthritis treatment: review of current evidence. Ther Adv Chronic Dis 10:2040622319825567. https://doi.org/10.1177/2040622319825567CrossRefPubMedPubMedCentral

55.

Cavallo C, Filardo G, Mariani E et al (2014) Comparison of platelet-rich plasma formulations for cartilage healing: an in vitro study. J Bone Joint Surg Am 96:423–429. https://doi.org/10.2106/JBJS.M.00726CrossRefPubMed

56.

Sen EI, Yildirim MA, Yesilyurt T, Kesiktas FN, Diracoglu D (2019) Effects of platelet-rich plasma on the clinical outcomes and cartilage thickness in patients with knee osteoarthritis. J Back Musculoskelet Rehabil. https://doi.org/10.3233/BMR-181209

57.

Altamura SA, Di Martino A, Andriolo L et al (2020) Platelet-rich plasma for sport-active patients with knee osteoarthritis: limited return to sport. Biomed Res Int 2020:8243865. https://doi.org/10.1155/2020/8243865CrossRefPubMedPubMedCentral

58.

Di Martino A, Di Matteo B, Papio T et al (2019) Platelet-rich plasma versus hyaluronic acid injections for the treatment of knee osteoarthritis: results at 5 years of a double-blind, randomized controlled trial. Am J Sports Med 47:347–354. https://doi.org/10.1177/0363546518814532CrossRefPubMed

59.

Papait A, Cancedda R, Mastrogiacomo M, Poggi A (2018) Allogeneic platelet-rich plasma affects monocyte differentiation to dendritic cells causing an anti-inflammatory microenvironment, putatively fostering wound healing. J Tissue Eng Regen Med 12:30–43. https://doi.org/10.1002/term.2361CrossRefPubMed

60.

Veronesi F, Pagani S, Torricelli P et al (2018) PRP and MSCs on tenocytes artificial wound healing: an in vitro study comparing fresh and frozen PRP. Histol Histopathol 33:1323–1334. https://doi.org/10.14670/HH-18-018CrossRefPubMed

61.

Assirelli E, Filardo G, Mariani E et al (2015) Effect of two different preparations of platelet-rich plasma on synoviocytes. Knee Surg Sports Traumatol Arthrosc 23:2690–2703. https://doi.org/10.1007/s00167-014-3113-3CrossRefPubMed

62.

Filardo G, Previtali D, Napoli F, Candrian C, Zaffagnini S, Grassi A (2020) PRP injections for the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials. Cartilage:1947603520931170. https://doi.org/10.1177/1947603520931170

63.

Lin KY, Yang CC, Hsu CJ, Yeh ML, Renn JH (2019) Intra-articular injection of platelet-rich plasma is superior to hyaluronic acid or saline solution in the treatment of mild to moderate knee osteoarthritis: a randomized, double-blind, triple-parallel, placebo-controlled clinical trial. Arthroscopy 35:106–117. https://doi.org/10.1016/j.arthro.2018.06.035CrossRefPubMed

64.

Kon E, Engebretsen L, Verdonk P, Nehrer S, Filardo G (2018) Clinical outcomes of knee osteoarthritis treated with an autologous protein solution injection: a 1-year pilot double-blinded randomized controlled trial. Am J Sports Med 46:171–180. https://doi.org/10.1177/0363546517732734CrossRefPubMed

65.

Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A (2013) Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med 41:356–364. https://doi.org/10.1177/0363546512471299CrossRefPubMed

66.

Southworth TM, Naveen NB, Tauro TM, Leong NL, Cole BJ (2019) The use of platelet-rich plasma in symptomatic knee osteoarthritis. J Knee Surg 32:37–45. https://doi.org/10.1055/s-0038-1675170CrossRefPubMed

67.

Chang KV, Hung CY, Aliwarga F, Wang TG, Han DS, Chen WS (2014) Comparative effectiveness of platelet-rich plasma injections for treating knee joint cartilage degenerative pathology: a systematic review and meta-analysis. Arch Phys Med Rehabil 95:562–575. https://doi.org/10.1016/j.apmr.2013.11.006CrossRefPubMed

68.

Dai WL, Zhou AG, Zhang H, Zhang J (2017) Efficacy of platelet-rich plasma in the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials. Arthroscopy 33(659–670):e651. https://doi.org/10.1016/j.arthro.2016.09.024CrossRef

69.

Mariani E, Roffi A, Cattini L et al (2020) Release kinetic of pro- and anti-inflammatory biomolecules from platelet-rich plasma and functional study on osteoarthritis synovial fibroblasts. Cytotherapy 22:344–353. https://doi.org/10.1016/j.jcyt.2020.02.006CrossRefPubMed

70.

Lana JF, Huber SC, Purita J et al (2019) Leukocyte-rich PRP versus leukocyte-poor PRP - the role of monocyte/macrophage function in the healing cascade. J Clin Orthop Trauma 10:S7–S12. https://doi.org/10.1016/j.jcot.2019.05.008CrossRefPubMedPubMedCentral

71.

Cavallo C, Roffi A, Grigolo B et al (2016) Platelet-rich plasma: the choice of activation method affects the release of bioactive molecules. Biomed Res Int 2016:6591717. https://doi.org/10.1155/2016/6591717CrossRefPubMedPubMedCentral

72.

Roffi A, Filardo G, Assirelli E et al (2014) Does platelet-rich plasma freeze-thawing influence growth factor release and their effects on chondrocytes and synoviocytes? Biomed Res Int 2014:692913. https://doi.org/10.1155/2014/692913CrossRefPubMedPubMedCentral

73.

Mariani E, Canella V, Cattini L et al (2016) Leukocyte-rich platelet-rich plasma injections do not up-modulate intra-articular pro-inflammatory cytokines in the osteoarthritic knee. PLoS One 11:e0156137. https://doi.org/10.1371/journal.pone.0156137CrossRefPubMedPubMedCentral

74.

Filardo G, Kon E, Longo UG et al (2016) Non-surgical treatments for the management of early osteoarthritis. Knee Surg Sports Traumatol Arthrosc 24:1775–1785. https://doi.org/10.1007/s00167-016-4089-yCrossRefPubMed

75.

Wang F, He X (2015) Intra-articular hyaluronic acid and corticosteroids in the treatment of knee osteoarthritis: a meta-analysis. Exp Ther Med 9:493–500. https://doi.org/10.3892/etm.2014.2131CrossRefPubMed

76.

Forogh B, Mianehsaz E, Shoaee S, Ahadi T, Raissi GR, Sajadi S (2016) Effect of single injection of platelet-rich plasma in comparison with corticosteroid on knee osteoarthritis: a double-blind randomized clinical trial. J Sports Med Phys Fitness 56:901–908PubMed

77.

Aoki KR (2005) Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 26:785–793. https://doi.org/10.1016/j.neuro.2005.01.017CrossRefPubMed

78.

Zhai S, Huang B, Yu K (2019) The efficacy and safety of botulinum toxin type A in painful knee osteoarthritis: a systematic review and meta-analysis. J Int Med Res:300060519895868. https://doi.org/10.1177/0300060519895868

79.

Han X, Yang B, Zou F, Sun J (2020) Clinical therapeutic efficacy of mesenchymal stem cells derived from adipose or bone marrow for knee osteoarthritis: a meta-analysis of randomized controlled trials. J Comp Eff Res 9:361–374. https://doi.org/10.2217/cer-2019-0187CrossRefPubMed

80.

Verhagen RA, Struijs PA, Bossuyt PM, van Dijk CN (2003) Systematic review of treatment strategies for osteochondral defects of the talar dome. Foot Ankle Clin 8:233–242, viii-ix. https://doi.org/10.1016/s1083-7515(02)00064-5CrossRefPubMed

81.

Dombrowski ME, Yasui Y, Murawski CD et al (2018) Conservative management and biological treatment strategies: proceedings of the international consensus meeting on cartilage repair of the ankle. Foot Ankle Int 39:9S–15S. https://doi.org/10.1177/1071100718779390CrossRefPubMed

82.

Pagliazzi G, Vannini F, Battaglia M, Ramponi L, Buda R (2018) Autologous chondrocyte implantation for talar osteochondral lesions: comparison between 5-year follow-up magnetic resonance imaging findings and 7-year follow-up clinical results. J Foot Ankle Surg 57:221–225. https://doi.org/10.1053/j.jfas.2017.05.013CrossRefPubMed

83.

Vannini F, Filardo G, Kon E, Roffi A, Marcacci M, Giannini S (2013) Scaffolds for cartilage repair of the ankle joint: the impact on surgical practice. Foot Ankle Surg 19:2–8. https://doi.org/10.1016/j.fas.2012.07.001CrossRefPubMed

84.

DeChellis DMCM (2011) Regenerative medicine in the field of pain medicine: prolotherapy, platelet-rich plasma therapy, and stem cell therapy—theory and evidence. Techniques in Regional Anesthesia and Pain Management 15(2):74–80. https://doi.org/10.1053/j.trap.2011.05.002CrossRef

85.

Faleiro TB, Schulz Rda S, Jambeiro JE, Tavares A, Delmonte FM, Daltro Gde C (2016) Viscosupplementation in ankle osteoarthritis: a systematic review. Acta Ortop Bras 24:52–54. https://doi.org/10.1590/1413-785220162401139470CrossRefPubMedPubMedCentral

86.

Vannabouathong C, Del Fabbro G, Sales B et al (2018) Intra-articular injections in the treatment of symptoms from ankle arthritis: a systematic review. Foot Ankle Int 39:1141–1150. https://doi.org/10.1177/1071100718779375CrossRefPubMed

Titel: Evidence on ankle injections for osteochondral lesions and osteoarthritis: a systematic review and meta-analysis
verfasst von: Angelo Boffa
Davide Previtali
Giorgio Di Laura Frattura
Francesca Vannini
Christian Candrian
Giuseppe Filardo
Publikationsdatum: 09.07.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: International Orthopaedics / Ausgabe 2/2021
Print ISSN: 0341-2695
Elektronische ISSN: 1432-5195
DOI: https://doi.org/10.1007/s00264-020-04689-5

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2021

Intraosseous injections of platelet rich plasma for knee bone marrow lesions treatment: one year follow-up

Autologous microfragmented adipose tissue reduces inflammatory and catabolic markers in supraspinatus tendon cells derived from patients affected by rotator cuff tears

Intra-articular gold induced cytokine (GOLDIC®) injection therapy in patients with osteoarthritis of knee joint: a clinical study

Hyaluronic acid and platelet-rich plasma for the management of knee osteoarthritis

Osteochondral autograft transplantation versus autologous bone-cartilage paste grafting for the treatment of knee osteochondritis dissecans